Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis.
Palacios S, Kalouche-Khalil L, Rizzoli R, Zapalowski C, Resch H, Adachi JD, Gallagher JC, Feldman RG, Kendler DL, Wang A, Wagman RB, Adami S.
Palacios S, et al. Among authors: gallagher jc.
Climacteric. 2015;18(6):805-12. doi: 10.3109/13697137.2015.1045484. Epub 2015 Sep 28.
Climacteric. 2015.
PMID: 26029985
Clinical Trial.